Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $8.8 million.

  • Fortress Biotech's Income from Continuing Operations rose 13302.9% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 3667.35%. This contributed to the annual value of -$120.9 million for FY2024, which is 2160.11% up from last year.
  • As of Q3 2025, Fortress Biotech's Income from Continuing Operations stood at $8.8 million, which was up 13302.9% from -$35.9 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Income from Continuing Operations ranged from a high of $8.8 million in Q3 2025 and a low of -$62.4 million during Q4 2021
  • For the 5-year period, Fortress Biotech's Income from Continuing Operations averaged around -$37.1 million, with its median value being -$35.9 million (2025).
  • In the last 5 years, Fortress Biotech's Income from Continuing Operations tumbled by 15968.02% in 2021 and then surged by 13302.9% in 2025.
  • Fortress Biotech's Income from Continuing Operations (Quarter) stood at -$62.4 million in 2021, then rose by 7.88% to -$57.4 million in 2022, then surged by 49.54% to -$29.0 million in 2023, then increased by 9.21% to -$26.3 million in 2024, then skyrocketed by 133.54% to $8.8 million in 2025.
  • Its Income from Continuing Operations was $8.8 million in Q3 2025, compared to -$35.9 million in Q2 2025 and -$21.8 million in Q1 2025.